Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Key Laboratory of Biological Targeted Therapy of Education Ministry and Hubei Province, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Br J Pharmacol. 2018 Apr;175(8):1329-1343. doi: 10.1111/bph.13781. Epub 2017 Apr 12.
The immune system plays an important role in driving the acute inflammatory response following myocardial ischaemia/reperfusion injury (MIRI). IL-21 is a pleiotropic cytokine with multiple immunomodulatory effects, but its role in MIRI is not known.
Myocardial injury, neutrophil infiltration and the expression of neutrophil chemokines KC (CXCL1) and MIP-2 (CXCL2) were studied in a mouse model of MIRI. Effects of IL-21 on the expression of KC and MIP-2 in neonatal mouse cardiomyocytes (CMs) and cardiac fibroblasts (CFs) were determined by real-time PCR and ELISA. The signalling mechanisms underlying these effects were explored by western blot analysis.
IL-21 was elevated within the acute phase of murine MIRI. Neutralization of IL-21 attenuated myocardial injury, as illustrated by reduced infarct size, decreased cardiac troponin T levels and improved cardiac function, whereas exogenous IL-21 administration exerted opposite effects. IL-21 increased the infiltration of neutrophils and increased the expression of KC and MIP-2 in myocardial tissue following MIRI. Moreover, neutrophil depletion attenuated the IL-21-induced myocardial injury. Mechanistically, IL-21 increased the production of KC and MIP-2 in neonatal CMs and CFs, and enhanced neutrophil migration, as revealed by the migration assay. Furthermore, we demonstrated that this IL-21-mediated increase in chemokine expression involved the activation of Akt/NF-κB signalling in CMs and p38 MAPK/NF-κB signalling in CFs.
Our data provide novel evidence that IL-21 plays a pathogenic role in MIRI, most likely by promoting cardiac neutrophil infiltration. Therefore, targeting IL-21 may have therapeutic potential as a treatment for MIRI.
This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.
免疫系统在驱动心肌缺血/再灌注损伤(MIRI)后的急性炎症反应中发挥重要作用。IL-21 是一种具有多种免疫调节作用的多功能细胞因子,但它在 MIRI 中的作用尚不清楚。
在 MIRI 的小鼠模型中研究了心肌损伤、中性粒细胞浸润以及中性粒细胞趋化因子 KC(CXCL1)和 MIP-2(CXCL2)的表达。通过实时 PCR 和 ELISA 测定 IL-21 对新生小鼠心肌细胞(CMs)和心肌成纤维细胞(CFs)中 KC 和 MIP-2 表达的影响。通过 Western blot 分析探讨了这些作用的信号机制。
IL-21 在 MIRI 的急性期升高。IL-21 中和减轻了心肌损伤,表现为梗死面积减小、心肌肌钙蛋白 T 水平降低和心功能改善,而外源性 IL-21 给药则产生相反的效果。IL-21 增加了 MIRI 后心肌组织中中性粒细胞的浸润,并增加了 KC 和 MIP-2 的表达。此外,中性粒细胞耗竭减轻了 IL-21 诱导的心肌损伤。机制上,IL-21 增加了新生 CMs 和 CFs 中 KC 和 MIP-2 的产生,并通过迁移试验增强了中性粒细胞的迁移。此外,我们证明这种 IL-21 介导的趋化因子表达增加涉及 CMs 中 Akt/NF-κB 信号的激活和 CFs 中 p38 MAPK/NF-κB 信号的激活。
我们的数据提供了新的证据,表明 IL-21 在 MIRI 中发挥致病作用,可能是通过促进心脏中性粒细胞浸润。因此,靶向 IL-21 可能具有治疗 MIRI 的治疗潜力。
本文是心血管疾病小分子聚焦特刊的一部分。要查看本特刊中的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.